Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ethyl alcohol (ethanol) absorption is the physiological process by which alcohol moves from the gastrointestinal tract into the bloodstream, occurring primarily through passive diffusion (StatPearls, 2023). Approximately 20% of absorption occurs in the stomach, while the remaining 80% takes place in the small intestine due to its significantly larger surface area (NIH/NIAAA). This process is not a specific molecular target, such as a receptor or enzyme, but rather a pharmacokinetic phase that is heavily influenced by the rate of gastric emptying. Drugs like metoclopramide can accelerate absorption by increasing gastric motility, whereas anticholinergic drugs like atropine may delay it (PubMed). While absorption is critical for determining the onset and peak of ethanol's effects on the central nervous system, it lacks the discrete molecular structure required to be classified as a therapeutic target itself.
Ethanol absorption is a passive process; drugs interact with this process by modulating gastric emptying rates or inhibiting first-pass metabolism by gastric alcohol dehydrogenase.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ethyl alcohol absorption.